1 azard ratio, 3.6 [CI, 2.2 to 5.9]), use of a multilumen catheter (hazard ratio, 2.8 [CI, 1.7 to 4.7])

2            Although CRBSI was more common in multilumen catheters (summary odds ratios, 2.15; 95% con

3 fection (CRBSI) and catheter colonization in multilumen catheters compared with single-lumen catheter

4 light increase in infectious risk when using multilumen catheters is likely offset by their improved

5 nly studies of higher quality were included, multilumen catheters were found not to be associated wit

6 tal clinic or physician's office, and use of multilumen catheters.

7 hlorhexidine-silver sulfadiazine-impregnated multilumen central venous catheters and nonimpregnated c

8                                              Multilumen central venous catheters may be associated wi

9                    Since the introduction of multilumen central venous catheters two decades ago, the

10                    The injection port of the multilumen endotracheal tube was used for the carinal pr

11 thetized rabbits were tracheostomized with a multilumen endotracheal tube.

12  Cdc42 causes a similar phenotype, including multilumen formation and reduced atypical protein kinase

13 tioned medium enhanced cell organization and multilumen formation, indicating that soluble signals se

14                            With the use of a multilumen perfusion catheter, we investigated the jejun

15 owing down cell division partially rescued a multilumen phenotype induced by altered polarity.

16                The occurrence of an aberrant multilumen phenotype was linked to fast nonequilibrium g

17  six positives were identified that caused a multilumen phenotype, including Tuba, a Cdc42-specific G

18 ay before the intervention (day 0), a 380-cm multilumen tube (1.75-mm diameter) with independent port

19 nce, thereby justifying the continued use of multilumen vascular catheters.